Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer
Juan P. Cerliani(Consejo Nacional de Investigaciones Científicas y Técnicas), Claudia Lanari(Consejo Nacional de Investigaciones Científicas y Técnicas)
Cited by 87
Related Papers
Progestin and antiprogestin responsiveness in breast cancer is driven by the <scp>PRA</scp>/<scp>PRB</scp> ratio <i>via</i><scp>AIB</scp>1 or <scp>SMRT</scp> recruitment to the <scp><i>CCND</i></scp><i>1</i> and <scp><i>MYC</i></scp> promoters
|International Journal of Cancer|2014|39
Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer
|Endocrine Related Cancer|2018|31